1. Home
  2. MIST vs INTT Comparison

MIST vs INTT Comparison

Compare MIST & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • INTT
  • Stock Information
  • Founded
  • MIST 2003
  • INTT 1981
  • Country
  • MIST Canada
  • INTT United States
  • Employees
  • MIST N/A
  • INTT N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • MIST Health Care
  • INTT Technology
  • Exchange
  • MIST Nasdaq
  • INTT Nasdaq
  • Market Cap
  • MIST 89.8M
  • INTT 77.3M
  • IPO Year
  • MIST N/A
  • INTT 1997
  • Fundamental
  • Price
  • MIST $1.60
  • INTT $7.53
  • Analyst Decision
  • MIST Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • MIST 2
  • INTT 2
  • Target Price
  • MIST $7.50
  • INTT $12.00
  • AVG Volume (30 Days)
  • MIST 1.8M
  • INTT 29.8K
  • Earning Date
  • MIST 08-07-2025
  • INTT 08-01-2025
  • Dividend Yield
  • MIST N/A
  • INTT N/A
  • EPS Growth
  • MIST N/A
  • INTT N/A
  • EPS
  • MIST N/A
  • INTT N/A
  • Revenue
  • MIST N/A
  • INTT $127,503,000.00
  • Revenue This Year
  • MIST N/A
  • INTT N/A
  • Revenue Next Year
  • MIST N/A
  • INTT $10.07
  • P/E Ratio
  • MIST N/A
  • INTT N/A
  • Revenue Growth
  • MIST N/A
  • INTT 5.19
  • 52 Week Low
  • MIST $0.63
  • INTT $5.24
  • 52 Week High
  • MIST $2.75
  • INTT $11.92
  • Technical
  • Relative Strength Index (RSI)
  • MIST 83.15
  • INTT 58.40
  • Support Level
  • MIST $1.86
  • INTT $7.01
  • Resistance Level
  • MIST $1.97
  • INTT $8.14
  • Average True Range (ATR)
  • MIST 0.14
  • INTT 0.45
  • MACD
  • MIST 0.06
  • INTT 0.02
  • Stochastic Oscillator
  • MIST 100.00
  • INTT 63.38

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: